Deep Remission Tied to RA Control - Top-Institutions - MDSpire

Deep Remission Tied to RA Control

At 5 years, 63% of patients in the CliDR group maintained sustained remission compared with 38% in the non-CliDR group.

  • By

  • Andrea Surnit

  • May 6, 2026

  • 4 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    The Johns Hopkins Hospital
    The Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Rheumatology

  • #2

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Rheumatology

  • #3

    Corrona
    Corrona

    Multiple Locations, USA

    Key Differentiators

    • Rheumatology

  • #4

    Medisch Spectrum Twente
    Medisch Spectrum Twente

    Enschede, Netherlands

    Key Differentiators

    • Rheumatology

  • #5

    Isala
    Isala

    Zwolle, Netherlands

    Key Differentiators

    • Rheumatology

Original Source(s)

Deep Remission Tied to RA Control

  • by Andrea Surnit

  • May 6, 2026

Related Content

Trial Exclusions May Skew RA Drug Comparisons

Nearly 40% of registry patients would have been excluded from phase 3 randomized controlled trials, with exclusion criteria distributed unevenly across drug classes.

Predicting anti-CCP positivity and early rheumatoid arthritis onset from routine laboratory parameters: a SHAP-explained machine learning pipeline

Impact of rheumatoid arthritis on complications and hospital outcomes following reverse shoulder arthroplasty: evidence from 389,135 hospitalizations in the national inpatient sample